Advertisement

The Effect of Citalopram on Midbrain CRF Receptors 1 and 2 in a Primate Model of Stress-Induced Amenorrhea

Abstract

We have demonstrated marked differences in the neurobiology of the serotonin system between stress-sensitive (SS) and stress-resilient (SR) cynomolgus macaques characterized in a model of stress-induced amenorrhea, also called functional hypothalamic amenorrhea (FHA). Dysfunction of the serotonin system in SS monkeys suggested that administration of a selective serotonin reuptake inhibitor (SSRI) might correct FHA. This study examines the effect of escitalopram (CIT) administration to SS and SR monkeys on corticotrophin-releasing factor (CRF) receptor 1 (CRF-R1) and CRF receptor 2 (CRF-R2) gene expression in the serotonin cell body region of the midbrain dorsal raphe. CRF-R1 was not significantly different between groups. There was a significant effect of treatment and a significant interaction between treatment and stress sensitivity on the average CRF-R2-positive pixel area (P < .004 and P < .006, respectively) and on the average number of CRF-R2-positive cells (P < .023 and P < .025, respectively). CIT significantly increased CRF-R2-positive pixel area and cell number in the SS group (pixel area P < .001; cell number P < .01; Bonferoni) but not in the SR group. In summary, CIT administration tended to decrease CRF-R1, but the small animal number precluded significance. CIT administration significantly increased CRF-R2 only in SS animals. These data suggest that the administration of CIT reduces anxiogenic components and increases anxiolytic components of the CRF system in the midbrain serotonin network, which in turn leads to improved ovarian function. Moreover, these data raise the possibility that SSRIs may be effective in the treatment of stress-induced infertility.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 510

This is the net price. Taxes to be calculated in checkout.

References

  1. 1.

    Reindollar RH, Novak M, Tho SP, McDonough PG. Adult-onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol. 1986;155(3): 531–543.

  2. 2.

    Giles DE, Berga SL. Cognitive and psychiatric correlates of functional hypothalamic amenorrhea: a controlled comparison. Fertil Steril. 1993;60(3): 486–492.

  3. 3.

    Marcus MD, Loucks TL, Berga SL. Psychological correlates of functional hypothalamic amenorrhea. Fertil Steril. 2001;76(2): 310–316.

  4. 4.

    Fioroni L, Fava M, Genazzani AD, Facchinetti F, Genazzani AR. Life events impact in patients with secondary amenorrhoea. J Psychosom Res. 1994;38(6): 617–622.

  5. 5.

    Laughlin GA, Dominguez CE, Yen SS. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab. 1998;83(1): 25–32.

  6. 6.

    Berga SL, Marcus MD, Loucks TL, Hlastala S, Ringham R, Krohn MA. Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy. Fertil Steril. 2003;80 (4): 976–981.

  7. 7.

    Tschugguel W, Berga SL. Treatment of functional hypothalamic amenorrhea with hypnotherapy. Fertil Steril. 2003;80(4):982–985.

  8. 8.

    Bethea CL, Centeno ML, Cameron JL. Neurobiology of stress-induced reproductive dysfunction in female macaques. Mol Neurobiol. 2008;38(3): 199–230.

  9. 9.

    Linthorst AC. Interactions between corticotropin-releasing hormone and serotonin: implications for the aetiology and treatment of anxiety disorders. Handb Exp Pharmacol. 2005;169: 181–204.

  10. 10.

    Luiten PG, ter Horst GJ, Karst H, Steffens AB. The course of paraventricular hypothalamic efferents to autonomic structures in medulla and spinal cord. Brain Res. 1985;329: 374–8.

  11. 11.

    Ruggiero DA, Underwood MD, Rice PM, Mann JJ, Arango V. Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioral implications. Neuroscience. 1999;91(4): 1343–1354.

  12. 12.

    Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci. 2002;23(2): 71–77.

  13. 13.

    Vaughan J, Donaldson C, Bittencourt J, et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 1995;378(6554): 287–292.

  14. 14.

    Lukkes JL, Forster GL, Renner KJ, Summers CH. Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphe differentially affect serotonin release in the nucleus accumbens. Eur J Pharmacol. 2008;578(2–3): 185–193.

  15. 15.

    Valdez GR, Inoue K, Koob GF, Rivier J, Vale W, Zorrilla EP. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res. 2002;943(1): 142–150.

  16. 16.

    Azmitia EC, Gannon PJ. The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv Neurol. 1986;43: 407–468.

  17. 17.

    Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiolog Rev. 1992;72(1): 165–231.

  18. 18.

    Bethea CL, Centeno ML. Ovarian steroid treatment decreases corticotropin-releasing hormone (CRH) mRNA and protein in the hypothalamic paraventricular nucleus of ovariectomized monkeys. Neuropsychopharmacology. 2008;33(3): 546–556.

  19. 19.

    Centeno ML, Sanchez RL, Reddy AP, Cameron JL, Bethea CL. Corticotropin-releasing hormone and pro-opiomelanocortin gene expression in female monkeys with differences in sensitivity to stress. Neuroendocrinology. 2007;86(4): 277–288.

  20. 20.

    Fuller RW. The involvement of serotonin in regulation of pituitary-adrenocortical function. Front Neuroendocrinol. 1992;13(3): 250–270.

  21. 21.

    Michelsen KA, Schmitz C, Steinbusch HW. The dorsal raphe nucleus–from silver stainings to a role in depression. Brain Res Rev. 2007;55(2): 329–242.

  22. 22.

    Clark MS, Kaiyala KJ. Role of corticotropin-releasing factor family peptides and receptors in stress-related psychiatric disorders. Semin Clin Neuropsychiatry. 2003;8(2): 119–136.

  23. 23.

    Reul JM, Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol. 2002;2(1): 23–33.

  24. 24.

    Maier SF, Watkins LR. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev. 2005;29(4–5): 829–841.

  25. 25.

    Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1): 85–102.

  26. 26.

    Li XF, Bowe JE, Kinsey-Jones JS, Brain SD, Lightman SL, O’Byrne KT. Differential role of corticotrophin-releasing factor receptor types 1 and 2 in stress-induced suppression of pulsatile luteinising hormone secretion in the female rat. J Neuroendocrinol. 2006;18(8): 602–610.

  27. 27.

    Rivier C, Rivier J, Vale W. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science. 1986;231(4738): 607–609.

  28. 28.

    Bethea CL, Pau FK, Fox S, Hess DL, Berga SL, Cameron JL. Sensitivity to stress-induced reproductive dysfunction linked to activity of the serotonin system. Fertil Steril. 2005;83(1): 148–155.

  29. 29.

    Lima FB, Centeno ML, Costa ME, Reddy AP, Cameron JL, Bethea CL. Stress sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram. Neuroscience. 2009;164(2): 676–691.

  30. 30.

    Bethea CL, Streicher JM, Mirkes SJ, Sanchez RL, Reddy AP, Cameron JL. Serotonin-related gene expression in female monkeys with individual sensitivity to stress. Neuroscience. 2005;132(1): 151–166.

  31. 31.

    Weissheimer KV, Herod SM, Cameron JL, Bethea CL. Interactions of corticotropin-releasing factor, urocortin and citalopram in a primate model of stress-induced amenorhea. Neuroendocrinology. 2010;92(4): 224–234.

  32. 32.

    Cameron JL, Bytheway JA, Guay S, et al. Treatment with a serotonin reuptake inhibitor increases reproductive hormone secretion in stress sensitive monkeys. 34th Annual Meeting of the Society for Neuroscience. San Diego, CA, 2004; Society for Neuroscience. Abstract 192.18.

  33. 33.

    Berg-von der Emde K, Dees WL, Hiney JK, et al. Neurotrophins and the neuroendocrine brain: different neurotrophins sustain anatomically and functionally segregated subsets of hypothalamic dopaminergic neurons. J Neurosci. 1995;15(6): 4223–4237.

  34. 34.

    Berga SL, Loucks TL. Use of cognitive behavior therapy for functional hypothalamic amenorrhea. Ann N Y Acad Sci. 2006;1092: 114–129.

  35. 35.

    Reame NE, Sauder SE, Case GD, Kelch RP, Marshall JC. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation. J Clin Endocrinol Metab. 1985;61(5): 851–858.

  36. 36.

    Berga SL, Loucks TL. The diagnosis and treatment of stress-induced anovulation. Minerva Ginecol. 2005;57(1): 45–54.

  37. 37.

    Ali MK, Lam RW. Comparative efficacy of escitalopram in the treatment of major depressive disorder. Neuropsychiatr Dis Treat. 2011;7: 39–49.

  38. 38.

    Portella MJ, de Diego-Adelino J, Ballesteros J, et al. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? a randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. J Clin Psychiatry. 2010;72(7): 962–969.

  39. 39.

    Entsuah AR, Huang H, Thase ME. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry. 2001;62(11): 869–877.

  40. 40.

    Kirby LG, Rice KC, Valentino RJ. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology. 2000;22(2): 148–162.

  41. 41.

    Pernar L, Curtis AL, Vale WW, Rivier JE, Valentino RJ. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J Neurosci. 2004;24(6): 1305–1311.

  42. 42.

    Müller MB, Zimmermann S, Sillaber I, et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci. 2003;6(10): 1100–1107.

  43. 43.

    Bailey JE, Papadopoulos A, Diaper A, et al. Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety. J Psychopharmacol. 2011;25(9): 1199–1206 [Epub ahead of print].

  44. 44.

    Licinio J, O’Kirwan F, Irizarry K, et al. Association of a corticotropin-releasing hormone receptor 1 haplotype and antide-pressant treatment response in Mexican-Americans. Mol Psychiatry. 2004;9(12): 1075–1082.

  45. 45.

    Herod SM, Bytheway J, Dolney R, Cameron JL. Female monkeys who are sensitive to stress-induced reproductive dysfunction also show increases in certain forms of anxious behavior. 36th Annual Meeting of the Society for Neuroscience. Atlanta, GA, 2006; Society for Neuroscience. Abstract #257.22.

  46. 46.

    Kirby LG, Freeman-Daniels E, Lemos JC, et al. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J Neurosci. 2008;28(48): 12927–12937.

  47. 47.

    Day HE, Greenwood BN, Hammack SE, et al. Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J Comp Neurol. 2004;474(3): 364–378.

  48. 48.

    Herod S, Cameron JL. Female monkeys sensitive to stress-induced reproductive dysfunction have low central drive to the reproductive axis in nonstressed conditions. Annual Meeting of the Endocrine Society. Toronto, Canada, 2007; Endocrine Society. Abstract P2–467.

  49. 49.

    Herod SM, Pohl CR, Cameron JL. Treatment with a CRH-R1 antagonist prevents stress-induced suppression of the central neural drive to the reproductive axis in female macaques. Am J Physiol Endocrinol Metab. 2011; 300(1): E19–E27.

  50. 50.

    Berga SL, Girton LG. The psychoneuroendocrinology of functional hypothalamic amenorrhea. Psychiatr Clin North Am. 1989;12(1): 105–116.

  51. 51.

    Bethea CL, Lima FB, Centeno ML, et al. Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity. J Chem Neuroanat. 2011;41(4): 200–218.

Download references

Author information

Correspondence to Cynthia L. Bethea.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Senashova, O., Reddy, A.P., Cameron, J.L. et al. The Effect of Citalopram on Midbrain CRF Receptors 1 and 2 in a Primate Model of Stress-Induced Amenorrhea. Reprod. Sci. 19, 623–632 (2012). https://doi.org/10.1177/1933719111430992

Download citation

Keywords

  • stress
  • selective serotonin reuptake inhibitor
  • corticotropin-releasing hormone receptors
  • dorsal raphe
  • serotonin
  • and macaques